Hims & Hers Health
Organization
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals, providing access to prescription and over-the-counter medications as well as personal care products.
What experts have said about Hims & Hers Health
4 statements · 1 positive · 3 negative
Hims & Hers shares are dropping after lowering its full-year profit outlook.
“shares dropping in the post market trade. This is after its full year profit outlook was lowered.”
Open the episode · Rocket Lab Falls, Hims Declines, Nvidia Announces Partnership with Wall Street BanksListen at 4:29
Hims & Hers stock is down about 22.8% after hours.
“Down about 22.8% in the post market trade.”
Open the episode · Rocket Lab Falls, Hims Declines, Nvidia Announces Partnership with Wall Street BanksListen at 4:37
Hims & Hers beat EPS estimates in six of the last ten quarters.
“The company has beat EPS estimate 6th of the last 10 quarters.”
Open the episode · Week Ahead: Hims & Hers, CoreWeave, Cava GroupListen at 1:17
Hims & Hers subscriber growth is currently slowing.
“However, that growth is kind of slowing down right now.”
Open the episode · Week Ahead: Hims & Hers, CoreWeave, Cava GroupListen at 1:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
8 episodes featuring Hims & Hers Health
Yet Another Value Podcast
Rate hikes expose hidden weakness beneath strong indexes
The episode connects delayed borrowing costs, shifting asset allocations, and investor psychology to a market that may look healthier than it is.
Sep 25, 2026 · 32 min
Yet Another Value Podcast
UK boards leave cheap stocks trapped in a valuation gap
The episode argues that low UK valuations reflect not only market sentiment but also governance, ownership, and capital-allocation failures that investors can challenge.
Sep 11, 2026 · 58 min
Raging Moderates with Scott Galloway and Jessica Tarlov
Foreign policy tests Democrats’ midterm strategy
The episode connects Democratic unity and Senate races to the military, media, and economic consequences of Trump’s foreign-policy agenda.
Aug 31, 2026 · 1h 1m
Stock Movers
Riot’s AI pivot lifts shares as Hims and On face pressure
The episode shows how sharply different growth stories—from peptide treatments to AI infrastructure—are reshaping investor expectations.
Aug 11, 2026 · 6 min
Stock Movers
Premium pricing rattles On Holding as three stocks slide
The episode shows how pricing decisions, strategic expansion, and unsold LNG cargoes can quickly reshape investor expectations.
Aug 11, 2026 · 6 min
Stock Movers
Nvidia partners with Wall Street giants as space and telehealth stocks fall
This episode highlights how massive capital is concentrating around AI infrastructure even as other high-growth sectors like space and telehealth face sharp corrections.
Aug 10, 2026 · 7 min
Stock Movers
AI demand meets costly infrastructure as earnings loom
The episode frames three different earnings tests: subscriber momentum and legal risk, AI infrastructure economics, and food-safety fallout.
Aug 9, 2026 · 9 min
The Herd with Colin Cowherd
Cormier questions Garry’s precise UFC 330 prediction
Garry’s confidence is central to the fight buildup, but Cormier argues that forecasting an exact finish could complicate how a victory is judged.
Jul 1, 2026 · 12 min